Results 31 to 40 of about 934,602 (387)
A single weekly Kt/Vurea target for peritoneal dialysis patients does not provide an equal dialysis dose for all [PDF]
, 2016 Copyright © 2016 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.Dialysis adequacy is traditionally based on urea clearance, adjusted for total body volume (Kt/Vurea), and clinical guidelines recommend a Kt/Vurea ...
Davenport, Andrew +4 more
core +2 more sources
Haemodialysis and peritoneal dialysis patients admitted to intensive care units. [PDF]
, 2007 Hutchison and colleagues report a 10-year experience of dialysis patients admitted to intensive care units (ICUs) in the UK excluding Scotland. Their study is the largest published so far and raises issues of interest to both ICU physicians and ...
Arulkumaran, N +2 more
core +2 more sources
Clinical Kidney Journal, 2014 A 32-year-old woman with known stage-4 chronic kidney disease due to lupus nephritis presented with twin pregnancy after in vitro fertilization at a gestational age of 24 weeks + 3 days because of imminent preterm labour. Repeated ultrasound evaluations confirmed intrauterine growth restriction in both twins and polyhydramnios as the cause of imminent ...
Gramkow, Ann-Maria +3 more
openaire +3 more sources
Roxadustat for Anemia in Patients with Kidney Disease Not Receiving Dialysis.
New England Journal of Medicine, 2019 BACKGROUND Roxadustat (FG-4592) is an oral inhibitor of hypoxia-inducible factor (HIF) prolyl hydroxylase that stimulates erythropoiesis and regulates iron metabolism.
N. Chen +20 more
semanticscholar +1 more source
Thrice weekly nocturnal in-centre haemodiafiltration: a 2-year experience [PDF]
, 2015 Background: Adequate control of plasma phosphate without phosphate binders is difficult to achieve on a thrice-weekly haemodialysis schedule. The use of quotidian nocturnal dialysis is effective but not practical in the in-centre setting.
Dey, V., Hair, M., Spalding, E. M.
core +1 more source
Serum levels and removal by haemodialysis and haemodiafiltration of tryptophan-derived uremic toxins in ESKD patients [PDF]
, 2020 Tryptophan is an essential dietary amino acid that originates uremic toxins that contribute to end-stage kidney disease (ESKD) patient outcomes.
Adoberg, A +15 more
core +1 more source
Brazilian Dialysis Census: analysis of data from the 2009-2018 decade
Jornal Brasileiro De Nefrologia, 2020 Introduction: National data on chronic dialysis treatment are essential for the development of health policies that aim to improve patient treatment. Objective: To present data from the Brazilian Society of Nephrology on patients with chronic dialysis ...
Precil D Neves +4 more
semanticscholar +1 more source
Home haemodialysis : trends in technology [PDF]
, 2011 Self management and home-based dialysis therapies offer the prospect of improved patient experience and outcomes. To allow more patients to realize these benefits requires changes in technology which focus on maximizing the ease and minimizing the ...
Farrington, Ken, Greenwood, Roger
core +2 more sources
Best Practice & Research Clinical Obstetrics & Gynaecology, 2019 Although kidney disease impacts on fertility, increasing numbers of pregnancies are reported in women on dialysis. Despite a trend of increasing live birth rates over recent decades, pregnancies on dialysis remain high risk with increased rates of adverse pregnancy outcomes including pregnancy loss, pre-eclampsia, pre-term delivery, low birth weight ...
Wiles, Kate, de Oliveira, Leandro
openaire +5 more sources
Cardiovascular disease in dialysis patients
Nephrology, Dialysis and Transplantation, 2018 Cardiovascular disease (CVD) is a highly common complication and the first cause of death in patients with end-stage renal disease (ESRD) on haemodialysis (HD).
M. Cozzolino +5 more
semanticscholar +1 more source